Andrea G. Hohmann
Andrea G. Hohmann
Verified email at - Homepage
Cited by
Cited by
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
A Zimmer, AM Zimmer, AG Hohmann, M Herkenham, TI Bonner
Proceedings of the National Academy of Sciences 96 (10), 5780-5785, 1999
An endocannabinoid mechanism for stress-induced analgesia
AG Hohmann, RL Suplita, NM Bolton, MH Neely, D Fegley, R Mangieri, ...
Nature 435 (7045), 1108-1112, 2005
The endocannabinoid system and pain
J Guindon, AG Hohmann
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNSá…, 2009
Altered nociceptive neuronal circuits after neonatal peripheral inflammation
MA Ruda, QD Ling, AG Hohmann, YB Peng, T Tachibana
Science 289 (5479), 628-630, 2000
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain
J Guindon, AG Hohmann
British journal of pharmacology 153 (2), 319-334, 2008
Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-α
J LoVerme, R Russo, G La Rana, J Fu, J Farthing, G Mattace-Raso, ...
Journal of Pharmacology and Experimental Therapeutics 319 (3), 1051-1061, 2006
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism
JR Clapper, G Moreno-Sanz, R Russo, A Guijarro, F Vacondio, A Duranti, ...
Nature neuroscience 13 (10), 1265-1270, 2010
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside
EJ Rahn, AG Hohmann
Neurotherapeutics 6 (4), 713-737, 2009
Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study
AG Hohmann, M Herkenham
Neuroscience 90 (3), 923-931, 1999
The cannabinoid system and pain
SG Woodhams, V Chapman, DP Finn, AG Hohmann, V Neugebauer
Neuropharmacology 124, 105-120, 2017
A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain
ME Lynch, P Cesar-Rittenberg, AG Hohmann
Journal of pain and symptom management 47 (1), 166-173, 2014
The endocannabinoid system and cancer: therapeutic implication
J Guindon, AG Hohmann
British journal of pharmacology 163 (7), 1447-1463, 2011
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain
P Anand, G Whiteside, CJ Fowler, AG Hohmann
Brain research reviews 60 (1), 255-266, 2009
Endocannabinoid mechanisms of pain modulation
AG Hohmann, RL Suplita
The AAPS journal 8, E693-E708, 2006
Cannabinoid receptors undergo axonal flow in sensory nerves
AG Hohmann, M Herkenham
Neuroscience 92 (4), 1171-1175, 1999
Localization of cannabinoid CB1 receptor mRNA in neuronal subpopulations of rat striatum: A double‐label in situ hybridization study
AG Hohmann, M Herkenham
Synapse 37 (1), 71-80, 2000
Pre-and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord
AG Hohmann, EM Briley, M Herkenham
Brain research 822 (1-2), 17-25, 1999
Selective activation of cannabinoid CB2 receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation
AG Nackley, A Makriyannis, AG Hohmann
Neuroscience 119 (3), 747-757, 2003
Cannabinoid mechanisms of pain suppression
JM Walker, AG Hohmann
Cannabinoids, 509-554, 2005
Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives
AG Hohmann
Chemistry and physics of lipids 121 (1-2), 173-190, 2002
The system can't perform the operation now. Try again later.
Articles 1–20